ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1304

Studying MR-Detected Inflammation in Symptom-Free Persons from the General Population to Generate Ramris-Based Reference Values

L. Mangnus1, H.W. van Steenbergen2, M. Reijnierse3 and A.H.M. van der Helm- van Mil1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: MRI, outcome measures and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: It is recommended by an EULAR imaging taskforce that MR-detected inflammation is useful in the diagnostic process of Rheumatoid Arthritis. This recommendation is based on the sensitivity of MR to detect inflammation. The specificity is unknown, but knowledge on the prevalence of MR-detected inflammation in symptom-free persons is pivotal when considering MR for diagnostic purposes. This prompted us to perform this study.

Methods: From November 2013-December 2014 196 symptom-free persons were recruited from the general population. Inclusion criteria were: no history of inflammatory arthritis, no joint symptoms during the last month and no clinically detectable arthritis at physical examination. Contrast-enhanced 1.5T MR-images of the dominant MCP, wrist and MTP joints were made and scored by two readers according to RAMRIS. At categorisation, MR-inflammation was considered present if both readers scored positive.

Results: Of 193 persons scanned (age range 19-89 years), only 28% had no single inflammatory-feature. Higher age correlated with higher inflammation-scores (p<0.001). Individual lesions were mostly grade-1. Preferential locations for synovitis were MCP-3 (14% in persons aged 40-59 years, 17% if aged ≥60 years). MCP-2 (8%, 19% respectively), wrist joints (8-35% if aged ≥40 years) and MTP-1 (11-13% if aged ≥40 years). BME was frequent at all ages in the lunate (6-27%) and MTP-1 (10-23%). Tenosynovitis was infrequent, except for extensor carpi ulnaris (9% in persons aged 40-59 years; 12% if aged ≥60 years).

Conclusion: MR-detected inflammation is prevalent in the absence of symptoms, especially at higher age and at preferential locations. Tables with RAMRIS-based and age, location and inflammation-type dependent prevalences were constructed.


Disclosure: L. Mangnus, None; H. W. van Steenbergen, None; M. Reijnierse, None; A. H. M. van der Helm- van Mil, None.

To cite this abstract in AMA style:

Mangnus L, van Steenbergen HW, Reijnierse M, van der Helm- van Mil AHM. Studying MR-Detected Inflammation in Symptom-Free Persons from the General Population to Generate Ramris-Based Reference Values [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/studying-mr-detected-inflammation-in-symptom-free-persons-from-the-general-population-to-generate-ramris-based-reference-values/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/studying-mr-detected-inflammation-in-symptom-free-persons-from-the-general-population-to-generate-ramris-based-reference-values/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology